ScholarIQanswers from OpenAlex & ORCID
Peter Nickerson
ResearcherPublications, citations & collaboration network
Peter Nickerson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Peter Nickerson have?
ScholarIQindexed works
Peter Nickerson has 295 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter Nickerson have?
ScholarIQcitation count
Peter Nickerson has 21,219 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Peter Nickerson?
ScholarIQh-index
Peter Nickerson has an h-index of 68 in OpenAlex.
What is the i10-index of Peter Nickerson?
ScholarIQi10-index
Peter Nickerson has an i10-index of 178 in OpenAlex.
What is the ORCID of Peter Nickerson?
ScholarIQorcid
The ORCID for Peter Nickerson is on the source record.
What is the OpenAlex record for Peter Nickerson?
ScholarIQopenalex
The OpenAlex for Peter Nickerson is on the source record.
What are the most-cited papers on Peter Nickerson?
ScholarIQmost cited works
The Banff 97 working classification of renal allograft pathology
Lorraine C. Racusen, Kim Solez, Robert B. Colvin, Stephen M. Bonsib, Maria Cristina Ribeiro de Castro, Tito Cavallo, Byron P. Croker, Anthony J. Demetris, Cynthia Drachenberg, Agnes B. Fogo, Peter Furness, Lillian W. Gaber, Ian W. Gibson, Dennis Glotz, J. Goldberg, Joseph P. Grande, Philip F. Halloran, Hans Erik Hansen, B. S. Hartley, P Häyry, Claire Hill, Ernesto O. Hoffman, Lawrence G. Hunsicker, Anne S. Lindblad, Niels Marcussen, M. J. Mihatsch, Tibor Nádasdy, Peter Nickerson, T. Steen Olsen, John C. Papadimitriou, Parmjeet S. Randhawa, David C. Rayner, S. A. Roberts, Stephen M. Rose, David N. Rush, Luis Salinas‐Madrigal, Daniel R. Salomon, Ståle Sund, E Taskinen, Kiril Trpkov, Yutaka Yamaguchi
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
Mark Haas, Alexandre Loupy, Carmen Lefaucheur, Candice Roufosse, Denis Glotz, Daniel Serón, Brian J. Nankivell, Philip F. Halloran, Robert B. Colvin, Enver Akalin, Nada Alachkar, Serena M. Bagnasco, Yassine Bouatou, Jan U. Becker, Lynn D. Cornell, J.P. Duong Van Huyen, Ian W. Gibson, Edward S. Kraus, Roslyn B. Mannon, Maarten Naesens, Volker Nickeleit, Peter Nickerson, Dorry L. Segev, Harsharan K. Singh, Mark D. Stegall, Parmjeet Randhawa, Lorraine C. Racusen, Kim Solez, Michael Mengel
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
Alexandre Loupy, Mark Haas, Candice Roufosse, Maarten Naesens, Benjamin Adam, Marjan Afrouzian, Enver Akalin, Nada Alachkar, Serena M. Bagnasco, Jan U. Becker, Lynn D. Cornell, Marian C. Clahsen‐van Groningen, Anthony J. Demetris, Duska Dragun, Jean–Paul Duong Van Huyen, Alton B. Farris, Agnes B. Fogo, Ian W. Gibson, Denis Glotz, Juliette Gueguen, Željko Kikić, Nicolas Kozakowski, Edward S. Kraus, Carmen Lefaucheur, Helen Liapis, Roslyn B. Mannon, Robert A. Montgomery, Brian J. Nankivell, Volker Nickeleit, Peter Nickerson, Marion Rabant, Lorraine C. Racusen, Parmjeet Randhawa, Blaise Robin, Ivy A. Rosales, Ruth Sapir‐Pichhadze, Carrie A. Schinstock, Daniel Serón, Harsharan K. Singh, R. Neal Smith, Mark D. Stegall, Adriana Zeevi, Kim Solez, Robert B. Colvin, Michael Mengel